Kite Pharma, Inc.
KITE
KITE was delisted on the 2nd of October, 2017.
187 hedge funds and large institutions have $2.26B invested in Kite Pharma, Inc. in 2015 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 64 increasing their positions, 48 reducing their positions, and 17 closing their positions.
194% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 17
33% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 48
22% more capital invested
Capital invested by funds: $1.86B → $2.26B (+$399M)
21% more funds holding
Funds holding: 155 → 187 (+32)
5% more call options, than puts
Call options by funds: $29.7M | Put options by funds: $28.2M
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$51.4M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$41M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$39.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$33.9M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$18.7M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$8.88M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.84M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$8.48M |
KITE Hedge Fund Activity: Q4 2015 in Review
187 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Kite Pharma, Inc. (KITE) for Q4 2015, worth a combined $2.26B — up 22% from $1.86B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new KITE positions and 17 closed out — a net gain of 33 holders — while 64 added to existing stakes and 48 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $51.4M. The largest seller was Frontier Capital Management, cutting an estimated $33.9M.
- 187 institutional investors held Kite Pharma, Inc. (KITE) as of Q4 2015, up from 155 in Q3 2015.
- Funds reported $2.26B of Kite Pharma, Inc. stock for Q4 2015, up 22% quarter-over-quarter.
- 50 funds opened new Kite Pharma, Inc. positions in Q4 2015 and 17 closed out, a net change of +33 holders.
- The largest Kite Pharma, Inc. buyer in Q4 2015 was JP Morgan Chase, an estimated $51.4M added.
- The largest Kite Pharma, Inc. seller in Q4 2015 was Frontier Capital Management, an estimated $33.9M sold.
Based on aggregated 13F filings for Q4 2015.